News
-
-
-
PRESS RELEASE
Institutional bondholders confirm willingness to serve on GZO AG Creditor Committee
Institutional bondholders confirm willingness to serve on GZO AG Creditor Committee. Key figures nominated include Gerber, Meili, Jakober, Eberle. Clearway Capital supports process for balanced representation -
PRESS RELEASE
Ouverture de la période de souscription à l'émission d'ORA de ONE EXPERIENCE d'un montant maximum de 3 M EUR à un taux de 15% par an
ONE EXPERIENCE lance une émission d'ORA pour lever 3M€ et renforcer sa stratégie financière à long terme. Découvrez les modalités de souscription sur https://groupe.one-experience.fr/ -
PRESS RELEASE
Ørsted provides preview of main points at today’s extraordinary general meeting and adjusts full-year EBITDA guidance for 2025
Ørsted provides updates from extraordinary general meeting including revised EBITDA guidance for 2025 and proposal for conducting a rights issue amidst challenges in the US wind market -
-
PRESS RELEASE
SFC Energy AG: Cavendish initiates coverage with “Buy” recommendation and price target of EUR 26.00 – upside potential of 70.4%
SFC Energy AG covered by Cavendish with 'Buy' recommendation of EUR 26.00 target price, reflecting 70.4% upside potential. Analyst praises market position, profitability, and successful mergers. Details at sfc.com -
-
PRESS RELEASE
Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues
Curatis Holding AG announces new distribution contract with Phoenix Labs (Ireland) for four products in Switzerland, expecting up to CHF 5 million additional annual revenues from October 2025 -
PRESS RELEASE
Newron to present data and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP)
Newron Pharmaceuticals to present data on evenamide as add-on treatment for schizophrenia at 2025 WCBP. Focus on efficacy, safety, and mechanism of action. Landmark studies showcased
